CoChat

Role of T Cell TGFβ Signaling and IL-17 in Allograft Acceptance and Fibrosis Associated with Chronic Rejection

Open access
Faust, Susan M, Lu, Guanyi, Marini, Bernard L, Zou, Weiping, Gordon, David, Iwakura, Yoichiro, Laouar, Yasmina, Bishop, D Keith · 2009 · The Journal of Immunology
Cited by 69

The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.

Abstract

Chronic allograft rejection (CR) is the main barrier to long-term transplant survival. CR is a progressive disease defined by interstitial fibrosis, vascular neointimal development, and graft dysfunction. The underlying mechanisms responsible for CR remain poorly defined. TGFβ has been implicated in promoting fibrotic diseases including CR, but is beneficial in the transplant setting due to its immunosuppressive activity. To assess the requirement for T cell TGFβ signaling in allograft acceptance and the progression of CR, we used mice with abrogated T cell TGFβ signaling as allograft recipients. We compared responses from recipients that were transiently depleted of CD4+ cells (that develop CR and express intragraft TGFβ) with responses from mice that received anti-CD40L mAb therapy (that do not develop CR and do not express intragraft TGFβ). Allograft acceptance and suppression of graft-reactive T and B cells were independent of T cell TGFβ signaling in mice treated with anti-CD40L mAb. In recipients transiently depleted of CD4+ T cells, T cell TGFβ signaling was required for the development of fibrosis associated with CR, long-term graft acceptance, and suppression of graft-reactive T and B cell responses. Furthermore, IL-17 was identified as a critical element in TGFβ-driven allograft fibrosis. Thus, IL-17 may provide a therapeutic target for preventing graft fibrosis, a measure of CR, while sparing the immunosuppressive activity of TGFβ.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.4049/jimmunol.0902446

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 80

  1. 2008, Mechanisms of chronic rejection in cardiothoracic transplantation., 2980
  2. 2000, Mechanisms of chronic rejection., 517
  3. 2006, Therapeutic targets in the treatment of allograft fibrosis., 867
  4. 1997, Chronic remodeling pathology in grafts., 676
  5. 2000, Chronic allograft dysfunction: mechanisms and new approaches to therapy., 126
  6. 2004, An update on clinical outcomes in heart and lung transplantation., S68
  7. 2006, Transforming growth factor-β regulation of immune responses., 99
  8. 1992, Targeted disruption of the mouse transforming growth factor-β1 gene results in multifocal inflammatory disease., 693
  9. 1993, Transforming growth factor-β1 knockout mice: a mutation in one cytokine gene causes a dramatic inflammatory disease., 3
  10. 2000, Abrogation of TGFβ signaling in T cells leads to spontaneous T cell differentiation and autoimmune disease., 171
  11. 2000, Disruption of T cell homeostasis in mice expressing a T cell-specific dominant negative transforming growth factor βII receptor., 1187
  12. 2007, TGFβ signalling in control of T-cell-mediated self-reactivity., 443
  13. 2001, Cell contact-dependent immunosuppression by CD4+CD25+ regulatory T cells is mediated by cell surface-bound transforming growth factor β., 629
  14. 2002, The role of IL-10 and TGFβ in the differentiation and effector function of T regulatory cells., 263
  15. 2003, Regulatory T cells in transplantation tolerance., 199
  16. 2005, Autoimmune disorders in Kabuki syndrome., 260
  17. 2008, CD4+ FoxP3+ regulatory T cells confer infectious tolerance in a TGFβ-dependent manner., 1975
  18. 2003, Conversion of peripheral CD4+CD25− naive T cells to CD4+CD25+ regulatory T cells by TGFβ induction of transcription factor Foxp3., 1875
  19. 2006, Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells., 235
  20. 2006, Transforming growth factor-β induces development of the TH17 lineage., 231
  21. 2006, TGFβ in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells., 179
  22. 2008, TGFβ-induced Foxp3 inhibits TH17 cell differentiation by antagonizing RORγt function., 236
  23. 2007, Development, cytokine profile and function of human interleukin 17-producing helper T cells., 950
  24. 2007, Th17 cells: effector T cells with inflammatory properties., 362
  25. 2007, IL-21 initiates an alternative pathway to induce proinflammatory TH17 cells., 484
  26. 2008, Induction and effector functions of TH17 cells., 1051
  27. 2008, The biological functions of T helper 17 cell effector cytokines in inflammation., 454
  28. 2009, TGFβ and fibrosis in different organs-molecular pathway imprints., 746
  29. 2007, IL-17 stimulates MMP-1 expression in primary human cardiac fibroblasts via p38 MAPK- and ERK1/2-dependent C/EBP-β, NF-κB, and AP-1 activation., H3356
  30. 2008, Resveratrol inhibits high glucose-induced PI3K/Akt/ERK-dependent interleukin-17 expression in primary mouse cardiac fibroblasts., H2078
  31. 2007, IL-17-dependent cellular immunity to collagen type V predisposes to obliterative bronchiolitis in human lung transplants., 3498
  32. 2001, IL-17 is increased in asthmatic airways and induces human bronchial fibroblasts to produce cytokines., 430
  33. 2007, Is cystic fibrosis a TH17 disease?., 221
  34. 2009, Antibodies to MHC class I induce autoimmunity: role in the pathogenesis of chronic rejection., 309
  35. 2009, Th17-polarized immune response in a murine model of hypersensitivity pneumonitis and lung fibrosis., 657
  36. 2004, Tregs and transplantation tolerance., 1398
  37. 2007, Role and mechanisms of CD4+CD25+ regulatory T cells in the induction and maintenance of transplantation tolerance., 120
  38. 1998, A critical role for transforming growth factor-β in donor transfusion-induced allograft tolerance., 1920
  39. 1998, Rejection of H-Y disparate skin grafts by monospecific CD4+ Th1 and Th2 cells: no requirement for CD8+ T cells or B cells., 1868
  40. 2007, A key role for TGFβ signaling to T cells in the long-term acceptance of allografts., 3648
  41. 2000, DNA-liposome versus adenoviral mediated gene transfer of transforming growth factor beta1 in vascularized cardiac allografts: differential sensitivity of CD4+ and CD8+ T cells to transforming growth factor α1., 1292
  42. 2005, Transforming growth factor-β1 gene transfer is associated with the development of regulatory cells., 2378
  43. 2006, Transforming growth factor β-induced connective tissue growth factor and chronic allograft rejection., 959
  44. 2002, Antigen-specific T cell sensitization is impaired in IL-17-deficient mice, causing suppression of allergic cellular and humoral responses., 375
  45. 1973, Primarily vascularized allografts of hearts in mice: the role of H-2D, H-2K, and non-H-2 antigens in rejection., 343
  46. 1994, Helper T lymphocyte unresponsiveness to cardiac allografts following transient depletion of CD4-positive cells: implications for cellular and humoral responses., 576
  47. 1999, Cytokine regulation of chronic cardiac allograft rejection: evidence against a role for Th1 in the disease process., 1548
  48. 2008, The classical complement pathway in transplantation: unanticipated protective effects of C1q and role in inductive antibody therapy., 1622
  49. 1998, High-resolution characterization of cytokine-producing alloreactivity in naive and allograft-primed mice., 906
  50. 2009, OX40 costimulation prevents allograft acceptance induced by CD40-CD40L blockade., 379
  51. 2009, Critical role for IL-6 in hypertrophy and fibrosis in chronic cardiac allograft rejection., 1773
  52. 2008, Transplant acceptance following anti-CD4 versus anti-CD40L therapy: evidence for differential maintenance of graft-reactive T cells., 2037
  53. 2002, The immunobiology of inductive anti-CD40L therapy in transplantation: allograft acceptance is not dependent upon the deletion of graft-reactive T cells., 323
  54. 1999, TGFβ and fibrosis., 1349
  55. 2007, TGFβ, cardiac fibroblasts, and the fibrotic response., 207
  56. 2000, The role of transforming growth factor β in chronic renal allograft nephropathy., 1759
  57. 2007, Antibody-mediated renal allograft rejection: diagnosis and pathogenesis., 1046
  58. 2009, Antibody-mediated rejection: treatment alternatives and outcomes., 34
  59. 2000, CD40-CD154 interactions in B-cell signaling., 73
  60. 2001, Passive transfer of alloantibodies restores acute cardiac rejection in IgKO mice., 727
  61. 2004, Beyond C4d: other complement-related diagnostic approaches to antibody-mediated rejection., 311
  62. 2005, Antibody-mediated rejection in human cardiac allografts: evaluation of immunoglobulins and complement activation products C4d and C3d as markers., 2778
  63. 2001, Scurfin (FOXP3) acts as a repressor of transcription and regulates T cell activation., 37672
  64. 2004, Induction of foxP3+ regulatory T cells in the periphery of T cell receptor transgenic mice tolerized to transplants., 6003
  65. 2004, Cutting edge: TGFβ induces a regulatory phenotype in CD4+CD25− T cells through Foxp3 induction and down-regulation of Smad7., 5149
  66. 2006, TGFβ1, a “Jack of all trades”: the link with pro-inflammatory IL-17-producing T cells., 358
  67. 2006, Regulatory T cells in transplantation., 111
  68. 2008, IL-23 and Th17 cells enhance Th2-cell-mediated eosinophilic airway inflammation in mice., 1023
  69. 2007, Possible implication of the effector CD4+ T-cell subpopulation TH17 in the pathogenesis of systemic scleroderma., 682
  70. 2004, Regulatory T cells and organ transplantation., 119
  71. 2004, Non-complement- and complement-activating antibodies synergize to cause rejection of cardiac allografts., 326
  72. 1999, Detection of humoral rejection in human cardiac allografts by assessing the capillary deposition of complement fragment C4d in endomyocardial biopsies., 904
  73. 2007, Achieving donor-specific hyporesponsiveness is associated with FoxP3+ regulatory T cell recruitment in human renal allograft infiltrates., 4901
  74. 2005, Recruitment of Foxp3+ T regulatory cells mediating allograft tolerance depends on the CCR4 chemokine receptor., 1037
  75. 2002, Identification of regulatory T cells in tolerated allografts., 1641
  76. 2005, T cells that cannot respond to TGFβ escape control by CD4+CD25+ regulatory T cells., 737
  77. 2006, T regulatory cells and migration., 1518
  78. 1990, Biological and clinical aspects of interleukin 6., 443
  79. 2007, IL-6 signaling pathway in keloids: a target for pharmacologic intervention?., 6
  80. 1991, Stimulation of collagen and glycosaminoglycan production in cultured human adult dermal fibroblasts by recombinant human interleukin 6., 686

Cited by

See all 69

Metadata

Authors
Faust, S. M., Lu, G., Marini, B. L., Zou, W., Gordon, D., Iwakura, Y., Laouar, Y., & Bishop, D. K.
Venue
The Journal of Immunology
Published
2009-12-01
Volume
183
Issue
11
Pages
7297-7306
ISSN
  • 0022-1767 (ISSN-L)
  • 1550-6606
OpenAlex
W2150750743
Cited by
69
References
4
FWCI
6.77
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.